세계의 실험실용 여과 시장 규모는 2025년부터 2032년까지 예측기간 동안 8.06%의 연평균 복합 성장률(CAGR)로 확대될 전망이며, 2024년 42억 7,000만 달러에서 2032년에는 79억 5,000만 달러로 성장할 것으로 예측되고 있습니다. 이 시장은 투자 증가, 나노 기술의 진전 걸음, 다액의 연구개발비, 바이오의약품 및 제약연구소에서 여과기술의 이용 확대에 의해 성장할 것으로 예측됩니다. 게다가 실험실내의 무균 환경에 대한 요구의 고조나, 의약품이나 백신을 제조하기 위한 고순도 개발 제품에 대한 강한 요구로부터, 새로운 성장이 전망됩니다.
실험실용 여과는 막과 여과지와 같은 필터 매체를 통해 액체와 기체로부터 고체 입자를 분리합니다. 이것은 제약, 바이오 테크놀로지, 식품 산업의 대부분의 연구, 품질 관리, 생산 프로세스에서 사용되는 표준 기술 중 하나입니다. 제약업계에서 실험실용 여과 수요는 매우 높으며, 그 주된 이유는 높은 순도와 정확도가 요구되기 때문입니다. 순도를 보장하고 제조 및 분석 중의 불순물을 제거합니다. 또한 의료 관련 기업들은 혁신적인 제품을 적극적으로 출시하고 있어 시장 성장에 기여하고 있습니다. 이 분야가 성장하고 있는 것은 암이나 자가면역 질환을 치료하기 위한 바이오치료제, 특히 단클론항체의 수요가 증가하고 있기 때문입니다.
본 보고서에서는 세계의 실험실용 여과 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 기술별, 최종 사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
Global laboratory filtration market is projected to witness a CAGR of 8.06% during the forecast period 2025-2032, growing from USD 4.27 billion in 2024 to USD 7.95 billion in 2032. The market is anticipated to grow due to increasing investments, enhanced nanotechnology advancements, significant R&D expenditures, and the growing utilization of filtration technologies in biopharmaceutical and pharmaceutical labs. Moreover, further growth arises from the increasing demand for a sterile environment in the lab and a strong requirement for highly purified development products to produce drugs and vaccines.
Laboratory filtration separates solid particles from liquids or gases through filter media like membranes or filter papers. This is one of the standard techniques used in most research, quality control, and production processes in the pharmaceutical, biotechnology, and food industries. The demand for laboratory filtration in the pharmaceutical industry is very high, primarily because of high purity and accuracy requirements. It assures purification and eliminates impurities during production and analysis. In addition, medical companies are aggressively launching innovative products that contribute to the market's growth. The sector is growing because of increasing demand for biotherapeutics, especially monoclonal antibodies, to treat cancer and autoimmune disorders. These developments enhance treatment options and help companies meet the needs of healthcare providers and patients. In October 2024, Asahi Kasei Medical Co., Ltd. released the Planova FG1, a virus removal filter with a flux much higher than its predecessor, Planova BioEX. It is approximately seven times faster than its predecessor, shortens virus filtration time, and reduces the risk of virus breakthrough during suspended processes. As the company continues to produce smaller filters in mass and deliver them to customers, Asahi Kasei Medical will continue to add larger filters to the product lineup to help customers scale up their operations.
Increasing Pharmaceutical Sterilization Boosts Market Demand
A rising trend of pharmaceutical sterilization contributes considerably to the growing demand for laboratory filtration. There is an increased regulatory demand within the pharmaceutical and medical industry that ensures drugs and medical equipment are pure and safe for human use. The filtration system directly supports removing contaminants, microorganisms, and particulates within production and quality control steps toward sterilization processes. Increasingly, better adoption of advanced filtration solutions will improve product efficiency while enabling manufacturers to keep abreast of changes in safety regulations. Moreover, filtration technology also helps make the whole process more convenient, minimizes the potential for contamination, and ensures the sterility of output products. Companies are investing in high-end testing solutions to test the filtration process. In October 2024, Nephros Inc. introduced the HydraGuard 20 UltraFilter. The product was specifically designed for medical device manufacturing and pharmaceutical production and guarantees the high-quality level of water purity that industries with strict quality standards need. Nephros Inc. seeks to enter the markets, including sterile processing and pharmaceuticals, because it meets their criteria.
Advancements in the Filtration Technology Support Market Expansion
Advances in filtration technology have considerably fortified the laboratory filtration market, and nanotechnology is emerging as a transformative force. Nanotechnology enables the creation of highly efficient filtration systems that offer improved precision and separation capabilities, answering the rising demand for high-purity laboratory filtration. Nano filters can remove particles at the molecular level, which enhances research, pharmaceuticals, and environmental testing outcomes. This technology is more precise and advances sustainability by wasting less and consuming less energy. In September 2024, DuPont de Nemours, Inc. received the Sustainability Technology of the Year award for FilmTec Nanofiltration Membranes. These nanofiltration membranes indicate the full potential of nanotechnology because they offer good performance coupled with sustainability, energy efficiency, and improved water recovery. Nanofiltration membranes separate multiple solutes within a liquid feed based on ionic charge and find applications in various areas like water purification, mining, industrial processes, microelectronics, and dairy processing. Such progress shows possibilities for nanotechnology to help laboratories worldwide use sustainable filtration solutions in the future.
Filtration Media Account for a Significant Share of the Market
The laboratory filtration market is growing significantly. This growth is driven by the increasing demand for advanced filtration media for laboratory filtration. Laboratory filtration is dominated by filtration media, which forms the core part of a filtration system, ensuring high precision, efficiency, and adaptability in a broad range of laboratory applications. Innovations in materials, such as micro-glass fibers, membranes, and advanced polymers, have improved the performance of filtration media, allowing laboratories to attain superior separation, purification, and contamination control. This dominance is further fueled by the pharmaceutical, biotechnology, and food testing industries, where accuracy and sterility are paramount. Because of the increasing focus on research and quality control, laboratories are shifting towards specialized filtration media that meet stringent regulatory standards. Sustainability initiatives are also driving the development of reusable and biodegradable filtration materials. Moreover, companies in various industries are investing to improve their filtration media product line. In June 2024, Ahlstrom Oyj announced investing in a new production line for molecular filtration media. This investment will increase its offerings for premium filtration applications and manufacture high-performance adsorbent materials.
North America Holds Major Market Share
North America dominates the laboratory filtration market with well-established pharmaceutical and biotechnology sectors, advanced research infrastructure, and strong regulatory requirements. Substantial investment in this region's research and development stimulates innovation in filtration technologies. Significant demand for advanced products in filtration in healthcare, environmental testing, and industrial applications will also further boost market growth. The presence of major industry players and a supportive ecosystem for startups also contribute to North America's market leadership. Growing investments in life sciences and healthcare and the well-defined regulatory standards in the region only increase the demand for laboratory filtration products. While biotech and pharmaceuticals prioritize advanced filtration systems to ensure quality and safety in their offerings, North America will undoubtedly continue its stranglehold on the laboratory filtration market. Furthermore, in June 2024, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, declared Siren Biotechnology Inc. as the North American winner of its 13th Advance Biotech Grant Program. Emerging biotech firms drive innovation and hold 60 percent of the drug pipeline. Siren Biotechnology will acquire products, technologies, and contract testing services to develop cancer gene therapy treatments. Such grants underscore the region's role as a hub for cutting-edge scientific progress, reinforcing its substantial market presence.
Future Market Scenario (2025 - 2032F)
The laboratory filtration market is expected to grow strongly, driven by increased research and development activities in the pharmaceutical, biotechnology, and food testing industries. The main growth drivers are the increasing demand for high-purity filtration solutions, advancements in membrane technology, and stringent regulatory standards for laboratory practices. With a growing focus on healthcare infrastructure, environmental testing, and nanotechnology developments will increase demand. Also, innovations and automation in lab equipment are poised to create efficiency, boosting the market's growth for the upcoming years.
Several innovations in filtration are propelling market growth and providing significant prospects. In June 2024, Cytiva c/o Global Life Sciences Solutions USA LLC launched Supor Prime sterilizing grade filters to better filtrate high-concentration biologics. Such filters allow for higher yields, decrease the occurrence of blockages, and reduce filtration costs. The growing demand for subcutaneous drugs, which patients can self-administer, fuels the trend as it minimizes intravenous injections within the clinic, thus effectively enabling critical therapies to reach their targets.
Key Players Landscape and Outlook
Leading players in the laboratory filtration market strengthen their positions through acquisitions, new product releases, and investments. These players are also working on partnership developments, technological advancements, and increasing the production capacity to meet the increasing demand. All these strategic moves keep them ahead in the market while continually innovating solutions related to filtration.
In December 2024, Ahlstrom Oyj acquired ErtelAlsop, a New York-based high-performance liquid depth filter media producer. The acquisition furthers Ahlstrom's market position and is among the company's key growth milestones. In addition, the integration of ErtelAlsop's technology is aligned with Ahlstrom's goal of becoming a sustainable specialty materials company. This acquisition further improves Ahlstrom's ability to meet varied product specifications for customers worldwide, demonstrating adaptability and foresight in an increasingly growing laboratory filtration market.
In September 2024, Sartorius AG launched a new crossflow filtration or Tangential Flow Filtration (TFF) system specifically designed for laboratory applications. TFF clarifies process fluids such as cell culture media and can concentrate on macromolecules, proteins, and viruses. Unlike all other systems, fluid here flows parallel to the filter, reducing the problem of clogging. This technique allows for continuous separation without fouling and provides effective filtration in most applications.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.